Concert Pharmaceuticals Reports Year Ended 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Concert Pharma (CNCE) Tops Q4 EPS by 7c
March 6, 2017 7:19 AM ESTConcert Pharma (NASDAQ: CNCE) reported Q4 EPS of ($0.54), $0.07 better than the analyst estimate of ($0.61).
For earnings history and earnings-related data on Concert Pharma (CNCE) click here.
... More